UV Germi (ALUVI) Stock Overview
Designs, manufactures, and sells ultraviolet devices for the treatment of air, water, and surfaces in France. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
ALUVI Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
UV Germi SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €2.98 |
| 52 Week High | €3.58 |
| 52 Week Low | €1.88 |
| Beta | -0.058 |
| 1 Month Change | 1.02% |
| 3 Month Change | 0% |
| 1 Year Change | 12.45% |
| 3 Year Change | -14.49% |
| 5 Year Change | -76.35% |
| Change since IPO | -46.60% |
Recent News & Updates
Recent updates
UV Germi's (EPA:ALUVI) Returns On Capital Are Heading Higher
Oct 31
Insufficient Growth At UV Germi SA (EPA:ALUVI) Hampers Share Price
Jul 10We Like These Underlying Return On Capital Trends At UV Germi (EPA:ALUVI)
Apr 14UV Germi SA's (EPA:ALUVI) Popularity With Investors Is Under Threat From Overpricing
Feb 15UV Germi (EPA:ALUVI) Might Have The Makings Of A Multi-Bagger
Dec 13UV Germi SA's (EPA:ALUVI) Business Is Trailing The Market But Its Shares Aren't
Aug 13We Like These Underlying Return On Capital Trends At UV Germi (EPA:ALUVI)
Apr 25Here's Why I Think UV Germi (EPA:ALUVI) Might Deserve Your Attention Today
Oct 23Some Confidence Is Lacking In UV Germi SA's (EPA:ALUVI) P/E
Sep 07Shareholder Returns
| ALUVI | FR Machinery | FR Market | |
|---|---|---|---|
| 7D | 2.1% | 6.1% | 1.4% |
| 1Y | 12.5% | 33.3% | 1.2% |
Return vs Industry: ALUVI underperformed the French Machinery industry which returned 31.7% over the past year.
Return vs Market: ALUVI exceeded the French Market which returned 0.7% over the past year.
Price Volatility
| ALUVI volatility | |
|---|---|
| ALUVI Average Weekly Movement | 3.4% |
| Machinery Industry Average Movement | 4.7% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in FR Market | 11.2% |
| 10% least volatile stocks in FR Market | 2.4% |
Stable Share Price: ALUVI has not had significant price volatility in the past 3 months compared to the French market.
Volatility Over Time: ALUVI's weekly volatility has decreased from 9% to 3% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 44 | Willy Fortunato | www.uvgermi.fr |
UV Germi SA designs, manufactures, and sells ultraviolet devices for the treatment of air, water, and surfaces in France. The company offers its products in the areas of drinking water, seawater, dechloramination, wastewater and industrial process water, private pool, legionella, germiserre, small flow rates, ageing, industrial clean water, and livestock farming industries. It also provides after-sales services, such as installations, online troubleshooting, technical advice, diagnostics, spare parts supplies, on-site intervention, and training on the use of the equipment.
UV Germi SA Fundamentals Summary
| ALUVI fundamental statistics | |
|---|---|
| Market cap | €9.48m |
| Earnings (TTM) | €709.93k |
| Revenue (TTM) | €8.88m |
Is ALUVI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALUVI income statement (TTM) | |
|---|---|
| Revenue | €8.88m |
| Cost of Revenue | €4.86m |
| Gross Profit | €4.01m |
| Other Expenses | €3.30m |
| Earnings | €709.93k |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.22 |
| Gross Margin | 45.21% |
| Net Profit Margin | 8.00% |
| Debt/Equity Ratio | 0.9% |
How did ALUVI perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/09 03:59 |
| End of Day Share Price | 2026/02/09 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
UV Germi SA is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Charles-Louis Planade | TPICAP Midcap |
| Valerie Ducreux Dieppe | TPICAP Midcap |
| Christel Cleme | TPICAP Midcap |